Conclusions
This case shows the feasibility and safety of HCR in selected patients
with multivessel CAD, highlighting how this hybrid technique combines
the advantages of surgical and percutaneous revascularization, both
guided by robotic techniques, eliminating at the same time some of the
disadvantages of both procedures. Moreover, the use of RE-MIDCAB graft
of the LIMA to the LAD and R-PCI to treat non LAD lesions could lead to
additional benefits in optimizing patient outcomes.
This case report of robotically-enhanced hybrid revascularization is an
example of a search towards a “value-based cardiovascular care” in
which the enhanced outcome mattering to the patient together with the
cost reduction through shortening of hospitalization and reduction of
well-known complications are the capital elements of the equation.